![Russell Hawkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Hawkinson
Plus aucun poste en cours
Profil
Russell Hawkinson worked as Vice President-Finance & Accounting at CTI BioPharma Corp.
from 2006 to 2007.
He then worked as Vice President-Finance at Corixa Corp.
from 1995 to 2005.
From 2007 to 2018, he served as Chief Financial Officer at Theraclone Sciences, Inc. He also worked as an Audit Senior Manager at Ernst & Young LLP (Missouri).
In addition, he worked as Chief Financial Officer at OncoResponse, Inc. from 2015 to 2018.
Most recently, he served as Senior Vice President-Finance at Silverback Therapeutics, Inc. from 2020 to 2022.
Mr. Hawkinson received his undergraduate degree from the University of Washington.
Anciens postes connus de Russell Hawkinson
| Sociétés | Poste | Fin |
|---|---|---|
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Directeur Financier/CFO | 01/06/2018 |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Directeur Financier/CFO | 01/06/2018 |
| CTI BIOPHARMA CORP. | Directeur Financier/CFO | 01/01/2007 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Directeur Financier/CFO | 01/01/2005 |
| ARS PHARMACEUTICALS, INC. | Directeur Financier/CFO | - |
Formation de Russell Hawkinson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
